Cannabix Technologies (OTCMKTS:BLOZF – Get Free Report) released its earnings results on Tuesday. The company reported ($0.01) EPS for the quarter, Zacks reports.
Cannabix Technologies Stock Down 4.2%
OTCMKTS:BLOZF opened at $0.42 on Wednesday. The company has a market cap of $51.30 million, a P/E ratio of -21.19 and a beta of 0.65. The firm’s 50 day moving average is $0.39 and its two-hundred day moving average is $0.41. Cannabix Technologies has a fifty-two week low of $0.20 and a fifty-two week high of $0.50.
Cannabix Technologies Company Profile
Cannabix Technologies Inc is a Canada-based developer of biosensor technologies focused on the rapid, non-invasive detection of cannabis impairment. The company’s flagship product is a handheld breathalyzer device designed to identify recent use of tetrahydrocannabinol (THC) within minutes of exhalation, offering law enforcement agencies, public safety organizations and workplace safety departments a potential tool to assess impairment in real time.
The Cannabix breathalyzer employs proprietary sensor arrays and on-board algorithms to distinguish THC molecules in breath samples, delivering results without the need for laboratory analysis.
See Also
- Five stocks we like better than Cannabix Technologies
- Do not delete, read immediately
- The Crash Has Already Started (Most Just Don’t See It Yet)
- ALERT: Drop these 5 stocks before January 2026!
- [No Brainer Gold Play]: “Show me a better investment.”
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Receive News & Ratings for Cannabix Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cannabix Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
